These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11672891)

  • 21. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
    Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
    Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
    Zomer A; Otsuka N; Hiramatsu Y; Kamachi K; Nishimura N; Ozaki T; Poolman J; Geurtsen J
    Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
    Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?].
    Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
    Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
    BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population dynamics and antigenic drift of
    Mir-Cros A; Moreno-Mingorance A; Martín-Gómez MT; Codina G; Cornejo-Sánchez T; Rajadell M; Van Esso D; Rodrigo C; Campins M; Jané M; Pumarola T; Fàbrega A; González-López JJ
    Emerg Microbes Infect; 2019; 8(1):1711-1720. PubMed ID: 31769735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.
    Tsang RS; Shuel M; Jamieson FB; Drews S; Hoang L; Horsman G; Lefebvre B; Desai S; St-Laurent M
    Int J Infect Dis; 2014 Nov; 28():65-9. PubMed ID: 25244999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.
    Brandal LT; Vestrheim DF; Bruvik T; Roness RB; Bjørnstad ML; Greve-Isdahl M; Steens A; Brynildsrud OB
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):913-924. PubMed ID: 35543837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines.
    van Loo IHM; Mooi FR
    Microbiology (Reading); 2002 Jul; 148(Pt 7):2011-2018. PubMed ID: 12101289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.
    Borisova O; Kombarova SY; Zakharova NS; van Gent M; Aleshkin VA; Mazurova I; Mooi FR
    Clin Vaccine Immunol; 2007 Mar; 14(3):234-8. PubMed ID: 17202309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.
    Muyldermans G; Piérard D; Hoebrekx N; Advani R; Van Amersfoorth S; De Schutter I; Soetens O; Eeckhout L; Malfroot A; Lauwers S
    J Clin Microbiol; 2004 Apr; 42(4):1614-9. PubMed ID: 15071014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of vaccination on Bordetella pertussis strains, China.
    Zhang L; Xu Y; Zhao J; Kallonen T; Cui S; Xu Y; Hou Q; Li F; Wang J; He Q; Zhang S
    Emerg Infect Dis; 2010 Nov; 16(11):1695-701. PubMed ID: 21029526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on Prn variation in the mouse model and comparison with epidemiological data.
    van Gent M; van Loo IH; Heuvelman KJ; de Neeling AJ; Teunis P; Mooi FR
    PLoS One; 2011 Mar; 6(3):e18014. PubMed ID: 21464955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.